403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
U.S. Clinical Trial Imaging Market To Worth USD 1,675.4 Million By 2034, Growing At 9.37% CAGR
| Table | Scope | |
| Market Size in 2025 | USD 748.09 Million | |
| Projected Market Size in 2034 | USD 1675.4 Million | |
| CAGR (2025 - 2034) | 9.37 | % |
| Market Segmentation | By Modality, By Therapeutic Area, By Technology/Service Type, By End User | |
| Top Key Players | ICON plc, Parexel International, Medpace Holdings, BioTelemetry, Radiant Sage, Bioclinica, PAREXEL Informatics, Invicro LLC, WorldCare Clinical, IXICO plc, Intrinsic Imaging LLC, Clario, Siemens Healthineers Clinical Trials Imaging, GE Healthcare Clinical Research Imaging, Perceptive Informatics, BioTel Research, Prism Clinical Imaging, PAREXEL Medical Imaging, Resonance Health Ltd., Keosys Medical Imaging, ICON plc, Parexel International, Medpace Holdings, BioTelemetry, Radiant Sage, Bioclinica, PAREXEL Informatics, Invicro LLC, WorldCare Clinical, IXICO plc, Intrinsic Imaging LLC, Clario, Siemens Healthineers Clinical Trials Imaging, GE Healthcare Clinical Research Imaging, Perceptive Informatics, BioTel Research, Prism Clinical Imaging, PAREXEL Medical Imaging, Resonance Health Ltd., Keosys Medical Imaging |
What are the Major Drivers in the U.S. Clinical Trial Imaging Market?
Specifically, the US is encouraging modernization of clinical trialsWhat are the Key Drifts in the U.S. Clinical Trial Imaging Market?
- In September 2025, Algernon Pharma secured $4M non-dilutive deal to unveil the U.S. neuroimaging clinics for Alzheimer's. In April 2025, Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment empowered by Spring Mountain Capital. In June 2025, Brainomix, an innovator in stroke artificial intelligence (AI) imaging solutions, and 3DR Labs partnered to assist acute stroke care in the US through the clinically validated and FDA-cleared Brainomix 360 Stroke.
What is the Developing Limitation in the U.S. Clinical Trial Imaging Market?
Mainly, the increasing need for the highest investment in equipment, including PET and MRI scanners, and the requirement for professionals are creating a hindrance to the market expansion, especially for small companies. Also, the management of large datasets, ensuring data security, and maintenance of standardization at different locations present crucial logistical and technical barriers.
You can place an order or ask any questions, please feel free to contact us at ...Country Analysis
How did the Northeast U.S. Dominate the Market in 2024?
In 2024, the Northeast U.S. held the biggest share of the market. The presence of a pharmaceutical and biotechnology companies hub, along with ongoing vital R&D investment is mainly promoting the innovations in the respective region. Nowadays, the market is leveraging the widespread developments in the integrated artificial intelligence (AI), the application of cloud-based data management, and the growth of decentralized clinical trials
Why did the West Coast Grow Notably in the U.S. Clinical Trial Imaging Market in 2024?
In the upcoming years, the West Coast will expand rapidly in the market. The market will be fueled by the presence of contract research organizations (CROs) in this country, like IQVIA and Icon plc, which are widely involved in the unification of advanced imaging data into the wider clinical data ecosystems, and have raised emphasis on AI & cloud approaches. Recent efforts, including the "Clinical Trials in Oncology West Coast 2024" event in San Francisco and the 2025 event in Burlingame, CA, are examples where discussion and showcasing of innovative developments have merged with the participation of Ergomed CRO.
U.S. Clinical Trial Imaging Market: Notable Efforts in 2023-2025
| "PRIMED-AI" program | In March 2025, NIH Common Fund activated this to allow precision medicine coupled with AI by integrating with clinical imaging and multimodal data. |
| FDA | In January 2025, it issued draft guidance on "Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products". |
| Clinical Trials Innovation Unit (CTIU) | In 2023, developed by NCI, which is "pressure testing" numerous innovations in trial design and conduct, such as technologies and processes. |
Global Clinical Trial Imaging Market Growth
The global clinical trial imaging market
To invest in our premium strategic solution and customized market report options, click here:Segmental Insights
By modality analysis
Which Modality Led the U.S. Clinical Trial Imaging Market in 2024?
The magnetic resonance imaging (MRI) segment captured the dominating share of the market in 2024. Emerging advances and benefits of this modality, such as high-resolution, non-ionising soft-tissue imaging, are making it necessary for monitoring the growth in trials for neurological, oncological, and cardiovascular concerns. The recent developments encompass the unveiling of the use of 7 Tesla (7T) MRI scanners in clinical trials, and Siemens Healthineers introduced the Magnetom Terra 7T for brain and knee imaging.
Moreover, the positron emission tomography (PET) segment is anticipated to grow at a rapid CAGR. Currently, the market is bolstering advances in hybrid solutions, such as the combination of PET's metabolic information with MRI's anatomical clarity or CT's anatomical detail, which expands diagnostic accuracy. The US leaders have developed and emphasized long axial field of view (LAFOV) or total-body PET systems (e.g., uEXPLORER, Panorama GS). Those facilitated increased image clarity, enhanced sensitivity, minimal scan times, and reduced radiation doses, also further allowing comprehensive whole-body diagnostics in a single session.
By therapeutic area analysis
What Made the Oncology Segment Dominant in the Market in 2024?
In 2024, the oncology segment led with a major share of the U.S. clinical trial imaging market. The US is facing a huge rise in cancer cases, and an expanded shift towards tailored and targeted therapies in oncology is boosting demand for sophisticated imaging.
- In August 025, the National Institutes of Health (NIH) awarded the UC Davis Department of Radiology a National Institute of Biomedical Imaging and Bioengineering R01 Research Project Grant with a budget of $2.5 million for four years, which will foster innovations in medical imaging techniques for cancer and bone and heart disease.
On the other hand, the neurology segment is estimated to register rapid expansion during 2025-2034. The key companies in the market are rigorously using AI for improving trial design, automating neuroimaging analysis (e.g., automated quantification of brain changes), and interpreting complex datasets. Besides this, the US has been stepping into imaging biomarkers are acting as a crucial factor in patient recruitment and stratification for clinical trials. Whereas the ongoing Alzheimer's Disease Neuroimaging Initiative (ADNI 4) study presents the validation of biomarkers for prospective AD clinical trials.
Get the latest insights on life science industry segmentation with our Annual Membership:By technology/service type analysis
How did the Image Analysis & Interpretation Segment Lead the Market in 2024?
The image analysis & interpretation segment dominated with a major share of the U.S. clinical trial imaging market in 2024. A prominent catalyst is a rise in emphasis on targeted therapiesHowever, the imaging CRO services segment will expand rapidly in the coming era. As these services are offering higher cost-effectiveness, accelerated R&D investment by diverse pharmaceutical
By end user analysis
Why did the Pharmaceutical & Biotechnology Companies Segment Dominate the Market in 2024?
In 2024, the pharmaceutical & biotechnology companies segment registered dominance in the U.S. clinical trial imaging market. These companies are raising their research and development budgets for developing novel drugsWhereas the contract research organizations (CROs) segment will expand at a rapid CAGR. CROs are widely reinforcing planned collaborations, including GE HealthCare's partnership with the Mayo Clinic, to promote innovation in medical imaging
Browse More Insights of Towards Healthcare:
The global clinical trial software market
The clinical trial design market
In 2024, the clinical trial central lab services market
The clinical trial biorepository and archiving solutions market
The clinical trial investigative site network market
The clinical trial supply and logistics market
The global clinical trial supplies market
Meanwhile, the global clinical trial services market
Lastly, the global oncology clinical trial market
What are the Latest Developments in the U.S. Clinical Trial Imaging Market?
- In August 2025, the medtech company DESKi launched HeartFocus, the transforming, AI-powered cardiac imaging software in the US. In January 2025, XingImaging, a MITRO company, a company in advanced research imaging and radiopharmaceutical services, opened its new state-of-the-art research facility in New Haven, Connecticut.
U.S. Clinical Trial Imaging Market Key Players List
- ICON plc (Imaging CRO division) Parexel International Medpace Holdings BioTelemetry (Philips) Radiant Sage (Parexel subsidiary) Bioclinica (ERT) PAREXEL Informatics Invicro LLC (Konica Minolta) WorldCare Clinical IXICO plc Intrinsic Imaging LLC Clario (formerly ERT & Bioclinica Imaging) Siemens Healthineers Clinical Trials Imaging GE Healthcare Clinical Research Imaging Perceptive Informatics (Parexel) BioTel Research Prism Clinical Imaging PAREXEL Medical Imaging Resonance Health Ltd. Keosys Medical Imaging ICON plc (Imaging CRO division) Parexel International Medpace Holdings BioTelemetry (Philips) Radiant Sage (Parexel subsidiary) Bioclinica (ERT) PAREXEL Informatics Invicro LLC (Konica Minolta) WorldCare Clinical IXICO plc Intrinsic Imaging LLC Clario (formerly ERT & Bioclinica Imaging) Siemens Healthineers Clinical Trials Imaging GE Healthcare Clinical Research Imaging Perceptive Informatics (Parexel) BioTel Research Prism Clinical Imaging PAREXEL Medical Imaging Resonance Health Ltd. Keosys Medical Imaging
Segments Covered in the Report
By Modality
- Magnetic Resonance Imaging (MRI) Computed Tomography (CT) Positron Emission Tomography (PET) Ultrasound X-ray & Others
By Therapeutic Area
- Oncology Neurology Cardiology Musculoskeletal Disorders Endocrinology & Metabolic Diseases Others (Rare & Infectious Diseases)
By Technology/Service Type
- Image Analysis & Interpretation Imaging Data Management Imaging CRO Services Software Solutions (AI/ML-enabled imaging platforms) Site Management & Training
By End User
- Pharmaceutical & Biotechnology Companies Academic & Research Institutions Medical Device Companies Contract Research Organizations (CROs)
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard:About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research You can place an order or ask any questions, please feel free to contact us at ...Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web:Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment